Patents by Inventor José Carlos Menendez

José Carlos Menendez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10357485
    Abstract: An anti-cancer compound is a compound having the following structural formula: or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: September 27, 2018
    Date of Patent: July 23, 2019
    Assignee: King Saud University
    Inventors: Abdulrahman Ibrahim Almansour, Raju Suresh Kumar, Natarajan Arumugam, Kotresha Dupadahalli, Jose Carlos Menendez
  • Patent number: 6656948
    Abstract: Compounds of the following formula: wherein all variables are as defined in the specification. The compounds have cytotoxic properties and can therefore be used in the treatment of malignant tumors.
    Type: Grant
    Filed: September 24, 2001
    Date of Patent: December 2, 2003
    Assignee: Universidad Complutense de Madrid
    Inventors: José Luis Fernandez Puentes, Dolores Garcia Gravalos, Carmen Avendano Lopez, Maria del Mar Blanco Castro, Jose Carlos Menendez Ramos
  • Patent number: 6525063
    Abstract: Compounds having formula (I) wherein R3, R4, R7 and R8 are independently selected from the group consisting of hydrogen, lower alkyl, halogen, amine, mono(lower)alkylamine, di(lower)alkylamine, phenyl, or substituted phenyl possess antitumor activity and are new with the exception of the compound in which R3, R4, R7, R8 are all hydrogen and the compound in which R3 and R7 are hydrogen, R4 is chlorine, and R8 is a 2-nitrophenyl group.
    Type: Grant
    Filed: July 11, 2001
    Date of Patent: February 25, 2003
    Assignee: Universidad Complutense de Madrid
    Inventors: Carmen Avendano, José María Perez, Maria del Mar Blanco, José Carlos Menendez, Dolores Garcia Gravalos, Jesús Angel de la Fuente, María Jesús Martin
  • Publication number: 20020128281
    Abstract: Compounds of formula (I), wherein X is selected from the group consisting of O, and NR3, where R3 represents a lower alkyl group; Y is selected from the group consisting of CH and N; R1 and R2 are independently selected from the group consisting of NH2, NHR4 and NR52, where R4 and R5 each represent a lower alkyl group, or R1 and R2 together represent a cycle selected from (a), (b) and (c), wherein R6, R7 and R8 are independently selected from the group consisting of hydrogen atoms, lower alkyl groups, hydroxy groups and lower alkoxy groups; and Z is selected from the group consisting of O.
    Type: Application
    Filed: September 24, 2001
    Publication date: September 12, 2002
    Applicant: Universidad Complutense de madrid
    Inventors: Jose Luis Fernandez Puentes, Dolores Garcia Gravalos, Carmen Avendano Lopez, Maria del Mar Blanco Castro, Jose Carlos Menendez Ramos
  • Publication number: 20020099066
    Abstract: 1 Compounds having formula (I) wherein R3, R4, R7, and R8 are independently selected from the group consisting of hydrogen, lower alkyl, halogen, amine, mono(lower)alkylamine, di(lower)alkylamine, phenyl, or substituted phenyl possess antitumor activity and are new with the exception of the compound in which R3, R4, R7, R8 are all hydrogen and the compound in which R3 and R7 are hydrogen, R4 chlorine, and R8 is a 2-nitrophenyl group.
    Type: Application
    Filed: July 11, 2001
    Publication date: July 25, 2002
    Inventors: Carmen Avendano, Jose Maria Perez, Maria del Mar Blanco, Jose Carlos Menendez, Dolores Garcia Gravalos, Jesus Angel de la Fuente, Maria Jesus Martin